Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
_________________________
Please print your name
____________________________
Please sign your name
Notes:
Please clearly organize your work, write legibly, show your computations for numerical answers,
and list your key assumptions. Points will be deducted for submissions that are illegible and
difficult to follow. The exam has 80 points, plus 6 points of extra credit (for part 1-c).
Problem 1 of 2: Ratio Analysis
Hertz Inc. (HRZ) is a pet food and supply company. Its comp in the below analysis is
International SuperPet Holdings (ISH).
a) Fill in the missing ratios for HRZ. (18 points).
HRZ
Q8
DtEV = Total Debt/(Total Debt + MV{Equity}) % 83.42%
Comps DtEV
46.11%
ROE(mv) = NI(eop)/MV{Equity, bop} %
Comps ROE(mv)
Q7
83.78%
53.15%
Q6
77.69%
45.36%
Q5
77.22%
39.02%
-67.00%
12.36%
-38.78%
30.77%
-76.87%
26.56%
20.37%
20.85%
3.19%
17.99%
-42.88%
20.86%
11.89%
22.11%
0.12%
19.52%
-3.28
5.97
-3.07
6.61
-3.92
4.82
-3.60
4.01
610.47
4.03
610.47
4.03
8.12%
6.66%
8.23%
6.01%
10.88%
7.11%
4.91%
8.34%
5.01%
6.46%
7.99%
7.98%
-10.77%
34.06%
39.88%
31.95%
257.69%
33.43%
-11.59%
34.15%
-31.82
4.80
7.81
5.89
11.36
7.12
199.39
7.16
PE(ttm) = MV{Equity}/NI(ttm)
Comps PE(ttm)
DY = Div/MV{Equity} %
Comps DY
PR = Div/NI %
Comps PR
EVtEBITDA = (Total Debt(bop) + MV{Equity, bop})/EBITDA(eop)
-10.38
Comps EVtEBITDA
7.08
35.34
4.85
E2261 Exam 2
Page 1
41.35% 4880.00%
28.65%
32.13%
9.36
6.18
12.53
6.06
HRZ
Sales ($MM)
Comps Sales
Q7
Q6
Q5
Q4
Q3
Q2
Q1
TTM
353
84
315
73
272
98
279
100
308
92
300
90
286
73
306
85
1,199
340
-12.65%
9.49%
-4.77%
23.52%
5.03%
-25.69%
9.73%
-14.73%
-1.54%
-4.17%
-10.75%
-13.76%
-13.44%
34.94%
2.24%
1.73%
10.59%
-7.52%
-2.69%
-2.71%
-4.54%
-18.82%
6.82%
16.74%
-1.54%
-4.17%
ROE = NI/OE(bop) %
Comps ROE
-56.74%
9.04%
-29.24%
18.52%
-99.52%
19.92%
36.13%
20.24%
5.29%
18.67%
-52.12%
17.75%
16.86%
15.58%
0.22%
18.94%
3.15%
13.40%
-6.45%
6.74%
-3.67%
9.68%
-11.17%
10.62%
2.73%
12.24%
0.43%
12.03%
-4.61%
14.54%
1.21%
11.28%
0.02%
12.44%
81.51%
74.85%
18.49%
25.15%
84.40%
77.17%
15.60%
22.83%
84.32%
79.61%
15.68%
20.39%
81.26%
77.05%
18.74%
22.95%
80.65%
77.68%
19.35%
22.32%
83.62%
76.95%
16.38%
23.05%
88.36%
75.31%
11.64%
24.69%
83.77%
72.27%
16.23%
27.73%
84.03%
75.62%
15.97%
24.38%
12.34%
12.10%
22.94%
15.41%
15.97%
11.62%
22.76%
12.83%
13.18%
11.59%
12.41%
14.48%
12.69%
13.31%
11.68%
12.34%
12.49%
12.91%
0.00%
2.14%
0.00%
2.06%
0.00%
1.53%
0.00%
1.40%
0.00%
1.63%
0.00%
1.89%
0.00%
2.19%
0.00%
2.82%
0.00%
2.12%
5.93%
5.32%
38.30%
0.00%
2.91%
-23.19%
-51.71%
-2.33%
0.00%
-7.06%
6.67%
-14.29%
0.00%
-8.00%
0.00%
0.00%
50.00%
-7.01%
1.34
0.68
1.25
0.90
1.27
0.92
1.45
0.81
1.43
0.73
1.40
0.59
1.46
0.60
1.41
0.75
12.03%
5.16%
2.37%
10.26%
0.30%
18.36%
-8.64%
4.57%
6.23
1.40
32.00
83.11
10.72%
7.87%
3.94%
11.81%
0.44%
21.46%
-4.58%
8.75%
5.23
1.93
38.93
111.57
12.28%
9.20%
3.13%
9.38%
0.46%
13.89%
-14.21%
9.80%
5.43
2.01
39.53
109.86
12.08%
7.87%
4.29%
12.03%
0.33%
19.44%
3.95%
9.94%
6.10
1.83
37.49
95.60
11.19%
9.56%
3.51%
12.41%
0.36%
32.53%
0.62%
8.72%
6.14
1.86
35.93
92.13
10.30%
7.41%
4.32%
11.22%
0.53%
30.76%
-6.45%
8.54%
5.92
1.38
33.37
70.84
11.88%
9.50%
4.99%
13.48%
0.41%
29.42%
1.77%
6.71%
6.47
1.11
37.65
91.11
10.70%
10.93%
4.00%
12.89%
0.38%
11.08%
0.02%
9.30%
5.94
1.68
38.03
85.73
10.91%
10.94%
4.07%
12.33%
0.38%
11.08%
6.57
1.98
6.38
2.12
7.00
2.03
9.15
2.04
8.54
2.14
8.08
2.08
9.52
2.32
8.98
2.20
8.98
2.20
64.83%
31.65%
61.07%
32.27%
64.39%
30.62%
65.75%
30.50%
65.54%
33.19%
62.91%
33.50%
66.13%
40.90%
65.94%
36.95%
65.94%
36.95%
80.99%
38.50%
79.57%
40.57%
81.85%
38.37%
85.74%
38.31%
84.84%
41.54%
83.56%
41.06%
86.29%
48.70%
85.56%
44.80%
85.56%
44.80%
12.92
3.03
-4.05
6.61
-13.68
3.94
-6.82
3.47
16.38
4.11
85.82
4.43
-10.39
6.43
37.56
4.35
2704.00
5.00
20.63%
26.47%
32.94%
31.73%
25.38%
23.18%
34.56%
25.23%
22.30%
24.13%
7.62%
-15.00%
20.51%
28.22%
-229.33%
23.98%
19.94%
27.50%
-21.90%
-2.78%
19.61%
29.11%
88.93%
-10.20%
20.58%
27.14%
-277.13%
-34.46%
1.58
2.18
1.23
2.27
1.37
2.26
1.16
2.26
1.23
1.64
1.00
1.42
1.16
1.18
1.15
1.64
1.15
1.64
1.08
2.20
1.20
2.19
0.99
2.21
1.05
1.61
0.83
1.39
1.00
1.16
0.98
1.57
0.98
1.57
39.61%
64.29%
22.38%
66.75%
31.88%
65.89%
20.27%
60.11%
26.93%
61.64%
10.58%
60.61%
23.17%
70.34%
22.63%
44.58%
22.63%
44.58%
-2.50
13.80
43.60
7.00
-25.70
-2.10
11.40
19.30
15.60
-28.70
43.20
-6.30
-35.60
-41.70
14.80
-6.60
38.00
-83.30
#DIV/0!
6.22
#DIV/0!
3.53
#DIV/0!
5.60
#DIV/0!
7.14
#DIV/0!
6.67
#DIV/0!
5.53
#DIV/0!
5.69
#DIV/0!
4.79
#DIV/0!
5.56
146.03%
548.28%
-137.50%
520.00%
136.36%
438.71%
-150.00% 2320.00%
129.91%
36.04%
320.41%
47.65%
53.33%
23.12%
441.46%
79.33%
502.61%
39.58%
0.00%
4.42%
0.00%
4.28%
0.00%
4.33%
0.00%
4.14%
0.00%
3.85%
0.00%
4.10%
0.00%
5.19%
83.60% 119.53%
427.27% 1020.00%
448.48%
325.00%
389.47% 1480.00%
50.49%
12.62%
289.80%
17.08%
940.00%
7.01%
353.66%
27.17%
500.87%
13.25%
WCR = WorkingCapital/WCAssets %
Comps WCR
NOCF = OCF - Capx
Comps NOCF
Fixed Coverage Ratio = EBIT/Interest
Comps FCR
EBITDA-S = EBITDA/(Interest + CAPX) %
Comps EBITDA-S
Interest Rate = INT/Total Debt (bop)
Comps Interest Rate
DT = Depreciation /CAPX %
Comps DT
0.00%
4.23%
E2261 Exam 2
Page 2
HRZ
Assets
Cash
Accounts Receivable
Short-Term Investments
Inventory
Other Current Assets
Total Current Assets
Q8
4.2
169.7
0.0
33.2
21.4
228.5
Q7
5.5
135.0
0.0
23.6
22.7
186.8
Q6
5.0
133.8
0.0
22.9
30.3
192.0
Q5
3.7
134.6
0.0
26.5
23.2
188.0
Q4
4.4
137.9
0.0
27.9
22.9
193.1
Q3
6.4
123.5
0.0
30.3
16.5
176.7
Q2
4.7
135.9
0.0
27.2
30.7
198.5
Q1
4.6
130.8
0.0
28.0
25.7
189.1
TTM
4.6
130.8
0.0
28.0
25.7
189.1
202.0
509.8
940.3
208.5
477.3
872.6
205.1
478.2
875.3
202.0
460.8
850.8
195.2
451.3
839.6
193.4
448.4
818.5
188.9
448.5
835.9
190.0
441.1
820.2
190.0
441.1
820.2
Liabilities
Accounts Payable
Short-Term Debt
Other Current Liabilities
Total Current Liabilities
Q8
27.3
6.5
110.7
144.5
Q7
41.9
6.6
103.1
151.6
Q6
28.8
9.7
102.0
140.5
Q5
38.8
12.8
111.1
162.7
Q4
34.9
15.9
106.2
157.0
Q3
43.3
18.8
114.7
176.8
Q2
50.5
18.8
102.0
171.3
Q1
41.0
18.8
105.3
165.1
TTM
41.0
18.8
105.3
165.1
Long-Term Debt
Other Liabilities
Total Liabilities
603.1
49.6
797.2
526.3
57.9
735.8
553.9
55.9
750.3
546.6
48.5
757.8
534.4
49.9
741.3
496.1
44.3
717.2
534.0
42.9
748.2
522.0
41.8
728.9
522.0
41.8
728.9
Shareholder's Equity
Equity (Common)
Q8
143.1
Q7
136.8
Q6
125.0
Q5
93.0
Q4
98.3
Q3
101.3
Q2
87.8
Q1
91.3
TTM
91.3
940.3
872.6
875.3
850.8
839.6
818.5
836.0
820.2
820.2
Q8
Q7
Q6
Q5
Q4
Q3
Q2
Q1
HRZ
TTM
352.6
287.4
43.5
0.0
9.9
11.8
0.7
0.0
11.1
314.7
265.6
72.2
0.0
9.8
-32.9
-12.6
0.0
-20.3
272.4
229.7
43.5
0.0
9.5
-10.3
-0.3
0.0
-10.0
278.5
226.3
63.4
0.0
9.3
-20.5
10.6
0.0
-31.1
308.0
248.4
40.6
0.0
10.6
8.4
0.0
0.0
8.4
299.7
250.6
37.2
0.0
10.4
1.5
0.1
0.1
1.3
286.1
252.8
36.3
0.0
10.3
-13.3
0.0
-0.1
-13.2
305.6
256.0
35.7
0.0
10.3
3.6
0.0
-0.1
3.7
1,199.4
1,007.8
149.8
0.0
41.6
0.2
0.1
-0.1
0.2
Income Statement
($MM UON)
Revenues
COGS
SGA
INT
Other Expenses/(Income)
Pretax Income
Tax
After Tax Expenses/(Income)
Net Income
E2261 Exam 2
Page 3
HRZ
Q8
11.1
15.8
-10.5
16.4
Q7
-20.3
15.3
61.4
56.4
Q6
-10.0
14.8
-27.2
-22.4
Q5
-31.1
14.8
31.5
15.2
Q4
8.4
14.8
-6.6
16.6
Q3
1.3
14.2
32.6
48.1
Q2
-13.2
14.1
-35.0
-34.1
Q1
3.7
14.5
0.7
18.9
TTM
0.2
57.6
-8.3
49.5
Q8
-18.9
0.2
-18.7
Q7
-12.8
0.2
-12.6
Q6
-3.3
0.1
-3.2
Q5
-3.8
0.7
-3.1
Q4
-1.0
0.1
-0.9
Q3
-4.9
0.3
-4.6
Q2
-1.5
0.1
-1.4
Q1
-4.1
1.3
-2.8
TTM
-11.5
1.8
-9.7
Q8
Q7
Q6
-17.5
-42.4
25.1
Q5
3.4
-16.8
-13.4
Q4
3.4
-18.5
-15.1
Q3
3.4
-44.8
-41.4
Q2
1.5
32.3
33.8
Q1
1.5
-17.7
-16.2
TTM
9.8
-48.7
-38.9
-19.8
1.4
4.2
-0.5
5.5
-1.3
5.0
0.6
3.7
2.1
4.4
-1.7
6.4
-0.1
4.7
0.9
3.7
4.2
5.5
1.3
5.0
-0.5
3.7
-1.3
4.4
0.7
6.4
2.0
4.7
-1.7
4.6
-0.1
4.6
0.9
Q8
4
30.3
Q7
3.4
30.34
Q6
5.32
30.42
Q5
5.42
30.44
Q4
5.35
30.43
Q3
4.04
30.48
Q2
4.08
30.52
Q1
3.99
30.6
TTM
3.99
30.6
Market Data
$MM except per share items
Stock Price
Average No. Shares
Stock Price Dates
ii.
As an expert pet supply analyst, you believe that industry participants must generally
maintain a cash level of at least 5.0% to be safe. Despite HRZs low cash level, might it
have enough quick access to cash for you to consider it safe? Why or why not?
iii.
As of the most recently reported quarter, which company has the better Working Capital
ratio? Why do you say its better?
E2261 Exam 2
Page 4
ii.
Describe in one sentence how you might improve HRZs SDItC ratios, and where you
would go to get the needed data.
E2261 Exam 2
Page 5
As of 3/31/20X0
3,000
4,000
3,000
1,000
Liabilities
Current Liabilities
Accounts Payable
Loan Payable
5,000
1,000
Noncurrent Liabilities
Pension Obligations
6,000
Noncurrent Assets
PPE
Less Deprecation
Net PPE
Goodwill
20,000
-8,000
12,000
4,000
Total Liabilities
12,000
Owners' Equity
15,000
Total Assets
27,000
Total L+OE
27,000
SMP also reported these notes to accompany the balance sheet ($MM UON):
Its PPE was established with a useful life of 5 quarters and $10,000 salvage value; the company uses
linear depreciation.
Its Loan obligation pays interest of $20 per quarter, and the principal ($1,000) must be paid on
12/31/20X0.
Its inception-to-date PIC was 1,000 and its inception-to-date dividends totaled 4,000.
E2261 Exam 2
Page 6
During the second quarter of 20X0 (Q2-20X0, ending 6/30/20X0), the company experienced the following
($MM UON):
1. Purchased inventory costing 4,000 on credit (ie: was invoiced).
2. Sold 20,000 of goods to customers, issued invoices for this amount, and noted that its total
inventory cost for these sales was 5,000.
3. Received invoices for 2,000 for some administrative costs in the quarter.
4. Paid 2,000 cash for Q2-20X0 R&D expenses. (R&D is not part of SGA for SMP).
5. Estimated (noted) Q2 taxes at $200.
6. Dealt with (in accounting terms) its PPE, associated depreciation, etc.
7. Noted that interest had accrued on its Loan Payable.
8. Paid its Q2 taxes (IE: paid $200).
Find:
a) (4 points) Fix the incorrect journal entries below. Journal entries (or parts of journal entries) from just
two economic events are wrong. (Hint: search one economic event at a time, and stop after you have
found two events with incorrect entries).
Event
Dr/Cr
Amount
Account
dr
cr
4,000
4,000
Inventory
AP
dr
cr
dr
cr
20,000
20,000
5,000
5,000
dr
cr
2,000
2,000
SGA Expense
AP
dr
cr
2,000
2,000
R&D Expense
Cash
dr
cr
200
200
dr
cr
dr
dr
cr
2,000
2,000
10,000
10,000
20,000
dr
cr
20
20
dr
cr
200
200
AR
Revenue
COGS Expense
Inventory
Tax expense
Accrued tax liability
Deprec. Expense
Accumulated Depreciation
Equipment held for sale
Accumulated Depreciation
PPE
Interest Expense
Accrued Interest Liability
Accrued tax liability
Cash
E2261 Exam 2
Page 7
b) (12 points) Using the corrected journal entries above (and anything else you need), create a
Delta Balance Sheet (BS) for SMPs Q2-20X0. IE: Create a report showing the changes to
SMPs balance sheet in Q2-20X0. You may report Owners Equity via a single account (IE:
Net Income), or you may show as many individual Equity accounts as you like. You do not
have to show any accounts (A/L/or E) that experienced no change during the quarter.
BS
Assets
Cash
AR
Inventory
Equipment held for sale
PPE
Accumulated Depreciation
Total Assets
Liabilities
Accrued Liabilities
AP
Equity
NI
Total Liabilities + Equity
(2,200)
20,000
(1,000)
10,000
(20,000)
8,000
14,800
20
6,000
8,780
14,800
c) (18 points) Prepare a Q2-20X0 Sources and Uses Statement for SMP. Show Net Income (NI)
as a single number, instead of showing individual Revenue and Expense accounts.
Sources and Uses Statement
Q2-20X0
Sources
Cash
Inventory
PPE
Accrued Liabilities
AP
NI
Total Sources
2,200
1,000
20,000
20
6,000
8,780
38,000
Uses
AR
Accumulated Depreciation
Equipment held for Sale
Total Uses
20,000
8,000
10,000
38,000
E2261 Exam 2
Page 8
d) (19 points) Compute an indirect cash-flow statement for SMPs Q2-20X0. In the Operating
portion, be sure to show a sub-total for cash-associated income.
Indirect CFS
Q2-20X0
8,780
2,000
10,780
- W Cap
= Cash from operations
-12,980
(2,200)
0
0
(2,200)
NA
20,000
-1,000
20
6,000
12,980
E2261 Exam 2
Page 9